产品编号 :
Cas No. :
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 2mg | 98% | 询价 | |||
| 5mg | 98% | 询价 | |||
| 10mg | 98% | 询价 | |||
| 25mg | 98% | 询价 | |||
| 50mg | 98% | 询价 |
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 2mg | 98% | 询价 | |||
| 5mg | 98% | 询价 | |||
| 10mg | 98% | 询价 | |||
| 25mg | 98% | 询价 | |||
| 50mg | 98% | 询价 |
CAS No. |
2096999-92-5 |
|---|---|
中文名称 |
5-乙基-2-氟-4-(3-(5-(1-甲基哌啶-4-基)-4,5,6,7-四氢-3H-咪唑并[4,5-c]吡啶-2-基)-1H-吲唑-6-基)苯酚 |
英文名称 |
5-Ethyl-2-fluoro-4-(3-(5-(1-methylpiperidin-4-yl)-4,5,6,7-tetrahydro-3H-imidazo[4,5-c]pyridin-2-yl)-1H-indazol-6-yl)phenol |
别名 |
JAK-IN-5;Phenol, 5-ethyl-2-fluoro-4-[3-[4,5,6,7-tetrahydro-5-(1-methyl-4-piperidinyl)-3H-imidazo[4,5-c]pyridin-2-yl]-1H-indazol-6-yl]-;Inhibitor,JAK,Janus kinase,inhibit,JAKIN5,JAK IN 5;5-ethyl-2-fluoro-4-(3-(5-(1-methylpiperidin-4-yl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridin-2-yl)-1H-indazol-6-yl)phenol;5-Ethyl-2-fluoro-4-(3-(5-(1-methylpiperidin-4-yl)-4,5,6,7-tetrahydro-3H-imidazo[4,5-c]pyridin-2-yl)-1H-indazol-6-yl)phenol;JAK inhibitor 1;JAK-IN-5, 10 mM in DMSO |
标准英文名 |
5-ethyl-2-fluoro-4-(3-(5-(1-methylpiperidin-4-yl)-4,5,6,7-tetrahydro-3H-imidazo[4,5-c]pyridin-2-yl)-1H-indazol-6-yl)phenol |
分子式 |
C27H31FN6O |
分子量 |
474.58 |
精确分子量 |
474.25 |
SMILES |
OC1=CC(CC)=C(C2=CC3=C(C=C2)C(C(N4)=NC5=C4CN(C6CCN(C)CC6)CC5)=NN3)C=C1F |
标准SMILES |
CN1CCC(CC1)N1CC2NC(=NC=2CC1)C1=NNC2C=C(C=CC=21)C1C=C(F)C(O)=CC=1CC |
性状 |
Powder or crystals |
用途 |
For laboratory research purposes. Not for drug or household use. |
信号词 |
Warning |
InChIKey |
YEGFDJOAFMPJSE-UHFFFAOYSA-N |
危险类别(旧) |
H302,H315,H319 |
存储要求 |
Inert atmosphere, 2-8°C,Keep container tightly closed in a dry and well-ventilated area. Containers which are opened must be carefully resealed and kept upright to prevent leakage. |
危险品分类 |
Acute toxicity, oral (Category 4),Skin corrosion/irritation (Category 2),Serious eye damage/eye irritation (Category 2A) |
|---|---|
化学稳定性 |
Stable under recommended storage conditions. |
符号 |
|
|
|
评论 |
|---|